To investigate the role of the YM fusion in regulating cancer cell malignancy in vitro, we employed short hairpin RNAs (shRNAs; shM2-1 and shM2-3) targeting the 3′ UTR and TAD sequences of the fusion/MAML2, respectively. This evidence concerns the gene MAML2 and cancer.